Inhalation & Nasal Dosage Manufacturing CDMOs in Europe
9 published
9 published CDMOs match Inhalation & Nasal Dosage Manufacturing in Europe.
Locations in this set include United States, France, China, United Kingdom, Switzerland, and Brazil.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, AAV / Viral Vector Platform, and Biologics (Monoclonal Antibodies).
Matching companies
CatalentGlobal CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
DelpharmTop-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
EthypharmEthypharm is a leading mid-size international specialty pharmaceutical company with strong European roots.
HovioneSpecialist integrated CDMO with over 60 years of experience in contract development and manufacturing for pharmaceutical customers, supporting both new and off-patent drug programs.
Kindeva Drug DeliveryPurpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities.
MedpharmSpecialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Siegfried HoldingGlobal CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
Unither PharmaceuticalsGlobal CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.
Markdown mirror: /services/inhalation-dosage-manufacturing/europe.md